NeoGenomics sales and marketing update

NeoGenomics launched NeoTYPE prognostic panel for chronic lymphocytic leukemia (CLL) in the U.S. The panel includes assays to detect mutations in the splicing factor 3B subunit 1 (SF3B1) gene, IgVH ...